DiCE Masterclass – Session V, Insights into Pancreatic Cancer

Online, Nov 4, 2021, 10:00 am
share

Our 6th Masterclass Series will run throughout 2021 as a virtual experience.

Insights into Pancreatic Cancer

On Thursday 18 November is World Pancreatic Cancer Day. To honour this, our November’s Masterclass focus will be on pancreatic cancer. This type of digestive cancer is particularly challenging. Lack of early signs and symptoms hinder its early diagnosis, while its treatment remains difficult. However, a lot is happening in pancreatic cancer basic and clinical research. Advances in precision medicine and clinical trial development as well as the continuous development of recommendations for the care of patients with pancreatic cancer reflect that the tool set we currently possess for improving outcomes is more powerful than in the past.

We are delighted to have four experts who will cover different aspects of pancreatic cancer, covering treatment challenges, genomic research, advances in clinical trials and the patient perspective.

AGENDA

Time (CET)

Speaker

Title

Topic

10.00–10.10Welcome & Introduction
10.10–10.35Prof. Alberto SobreroHead of the Medical Oncology Unit at Ospedale San Martino, GenovaChallenges of Pancreatic Cancer Treatment & Care
10.35–11.00Prof. Nuria MalatsHead of the Genetic and Molecular Epidemiology. Group at the Spanish National Cancer Research Centre (CNIO), MadridGenomics in Primary and Secondary Prevention of Pancreatic Cancer
11.00–11.25Dr. Benedikt WestphalenMedical Lead Precision Oncology, Comprehensive Cancer Center, University of MunichClinical trials in Pancreatic Cancer – the Road Ahead

 

11.25–11.50Ms. Patrycja RzadkowskaPatient Expert & Pancreatic Cancer Patient AdvocateLiving with Pancreatic Cancer – the Patient Perspective
11.50–12.00Final Remarks & Closing

About the Speakers

Prof Alberto Sobrero

Alberto Sobrero is Head of Medical Oncology at Ospedale San Martino in Genova, Italy. After his MD in Genova, he took up the position of postdoctoral Associate in Medical Oncology at Yale University, for 5 years and completed a residency in Internal Medicine at the Yale Affiliated Norwalk Hospital.

From 2002 to 2006, Professor Sobrero has been the Chairman of the Protocol Review Committee of the EORTC. He has served on the editorial board of the Journal of Clinical Oncology, has been part of the Scientific Committee of ASCO (2007-2008), and Chaired the GI committee of ESMO. He received the ESMO award in 2017. Recently he has launched a patient dedicated site www.youtumor.org to support patient information and empowerment. His main research interests include gastrointestinal cancer treatment and design and interpretation of clinical trials in oncology.

Prof Nuria Malats

Núria Malats is the Head of the Genetic and Molecular Epidemiology Group at the Spanish National Cancer Research Centre (CNIO). She obtained her MD in 1986 and her PhD in 1995 from the Universitat Autónoma de Barcelona and was one of the first scientists working in genetic and molecular epidemiology in Spain. From 1992-1995 she coordinated a national multicentre project on the molecular epidemiology of pancreatic cancer (PANKRAS2). She is principal investigator of the European Study on Pancreatic Cancer Genetics and Epidemiology (PanGen-EU) and co-PI of the Spanish Bladder Cancer/EPICURO Study, both being large case-control/cohort studies integrating scientific interests from different disciplines in cancer development and progression. In addition, she is the Spanish delegate of the Public Health Genomics European Network (PHGEN).

 

Dr Benedikt Westphalen

Benedikt Westphalen studied Medicine and Molecular Biology in Hamburg, Philadelphia, New York and Bern. Benedikt started training in Internal Medicine at the University of Hamburg, Germany. In 2010, Dr Westphalen joined the laboratory of Timothy C. Wang at Columbia University in New York City as a postdoctoral fellow. His studies were focused on cellular plasticity and the origins of gastrointestinal malignancies. After postdoctoral training, he joined the department of haematology and oncology at the University of Munich, Germany, in 2013. In Munich, Dr Westphalen focused on clinical and translational research in pancreatic cancer. Since 2017 he heads the Precision Oncology Program at his institution.

 

Ms Patrycja Rzadkowska

I am a psychologist, currently working for an international company. Additional to psychology, I am also psycho-oncology graduate. After my everyday job, I voluntarily work for EuropaColon Poland which led me to be a member of Patient Advisory Committee by European Cancer Organization and member of Pancreatic Cancer Europe. Four years ago, I was diagnosed with pancreatic cancer and after successful treatment, I have decided to share my story with others, hoping it can do some good. I am passionate about helping and supporting and that’s why I am a volunteer and get involved in different initiatives focused on oncology.

Masterclass 2021 – Full Agenda

2021 Dates

Time (CET)

Title

Type

April 152:00 PM – 4:00 PMOesophageal and Gastric CancersInteractive online session
May 2010:00 AM – 1:00 PMHow to Use Google Ads and Insights on FundingCommunication Workshop
July 610:00 AM – 12:00 PMUpdate in ScienceLecture
October 2610:00 AM – 12:00 PMLiver CancerLive Webinar
November 410:00 AM – 12:00 PMPancreatic CancerLive Webinar

Would you like more information? Please contact us.

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.